These videos will provide valuable insights and updates on cancer cachexia research from ASCO 2025
Prof. Dunne presents key studies from the ASCO conference indicating that cancer cachexia worsens survival outcomes, particularly affecting older adults and being more prevalent in Black/African American patients, possibly due to social, environmental, and biological factors.
Prof. Crawford highlights key studies from ASCO 2025 that focus on the therapeutic potential of agents inhibiting GDF-15/GFRAL in treating cancer cachexia.